Patents by Inventor Tarek Hamouda

Tarek Hamouda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOEMULSION AND METHODS OF USE THEREOF
    Publication number: 20230330202
    Abstract: The present disclosure relates to compositions and methods for inducing an immune response to a composition of the invention in a subject. Additionally, the present disclosure generally relates to methods for screening for immune response to a composition of the invention.
    Type: Application
    Filed: May 8, 2023
    Publication date: October 19, 2023
    Inventors: Shabaana Abdul Khader, Mushtaq Ahmed, Ali Fattom, Douglas Smith, Tarek Hamouda
  • Nanoemulsion and methods of use thereof
    Patent number: 11642405
    Abstract: The present disclosure relates to compositions and methods for inducing an immune response to a composition of the invention in a subject. Additionally, the present disclosure generally relates to methods for screening for immune response to a composition of the invention.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: May 9, 2023
    Assignees: Washington University, BLUEWILLOW BIOLOGICS
    Inventors: Shabaana Abdul Khader, Mushtaq Ahmed, Ali Fattom, Douglas Smith, Tarek Hamouda
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINES AND METHODS OF USING THE SAME
    Publication number: 20220105172
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: October 18, 2021
    Publication date: April 7, 2022
    Applicant: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • Herpes simplex virus nanoemulsion vaccine
    Patent number: 11147869
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: October 19, 2021
    Assignee: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, Jr., Tarek Hamouda, Vira Bitko
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINE
    Publication number: 20200197511
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: November 15, 2018
    Publication date: June 25, 2020
    Applicant: NanoBio Corporation
    Inventors: Ali I. FATTOM, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • NANOEMULSION AND METHODS OF USE THEREOF
    Publication number: 20200113990
    Abstract: The present disclosure relates to compositions and methods for inducing an immune response to a composition of the invention in a subject. Additionally, the present disclosure generally relates to methods for screening for immune response to a composition of the invention.
    Type: Application
    Filed: June 19, 2018
    Publication date: April 16, 2020
    Inventors: Shabaana Abdul Khader, Mushtaq Ahmed, Ali Fattom, Douglas Smith, Tarek Hamouda
  • Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
    Patent number: 10596251
    Abstract: The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: March 24, 2020
    Assignee: NanoBio Corporation
    Inventors: Ali I. Fattom, Tarek Hamouda, Vira Bitko, James R. Baker, Jr.
  • Nanoemulsion influenza vaccine
    Patent number: 10525121
    Abstract: The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: January 7, 2020
    Assignee: NanoBio Corporation
    Inventors: Tarek Hamouda, Joyce A. Sutcliffe, James R. Baker, Jr.
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINE
    Publication number: 20190083606
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: November 15, 2018
    Publication date: March 21, 2019
    Applicant: NanoBio Corporation
    Inventors: Ali I. FATTOM, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • Herpes simplex virus nanoemulsion vaccine
    Patent number: 10206996
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: February 19, 2019
    Assignee: NanoBio Corporation
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, Jr., Tarek Hamouda, Vira Bitko
  • NANOEMULSION RESPIRATORY SYNCYTIAL VIRUS (RSV) SUBUNIT VACCINE
    Publication number: 20170360919
    Abstract: The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
    Type: Application
    Filed: January 27, 2017
    Publication date: December 21, 2017
    Applicant: NanoBio Corporation
    Inventors: Ali I. Fattom, Tarek Hamouda, Vira Bitko, James R. Baker, JR.
  • Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
    Patent number: 9561271
    Abstract: The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: February 7, 2017
    Assignee: NanoBio Corporation
    Inventors: Ali I. Fattom, Tarek Hamouda, Vira Bitko, James R. Baker, Jr.
  • Human respiratory syncytial virus vaccine
    Patent number: 9492525
    Abstract: The present invention relates to RSV vaccines and methods for inducing an immune response to RSV in a subject comprising administering an RSV vaccine.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 15, 2016
    Assignee: NANOBIO CORPORATION
    Inventors: Ali I. Fattom, Nicolas Lukacs, James R. Baker, Jr., Vira Bitko, Tarek Hamouda
  • NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20160158179
    Abstract: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
    Type: Application
    Filed: February 11, 2016
    Publication date: June 9, 2016
    Inventors: James R. Baker, Jr., Mark R. Hemmila, Stewart C. Wang, Tarek Hamouda, John J. LiPuma, Jessica Ann Knowlton, Paul E. Makidon, Luz Blanco, Jeffery V. Groom, II, Anna U. Bielinska
  • NANOEMULSION INFLUENZA VACCINE
    Publication number: 20160074504
    Abstract: The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.
    Type: Application
    Filed: September 24, 2015
    Publication date: March 17, 2016
    Applicant: NanoBio Corporation
    Inventors: Tarek Hamouda, Joyce A. Sutcliffe, James R. Baker, JR.
  • Nanoemulsion therapeutic compositions and methods of using the same
    Patent number: 9259407
    Abstract: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: February 16, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: James R. Baker, Jr., Mark R. Hemmila, Stewart C. Wang, Tarek Hamouda, John J. LiPuma, Jessica Ann Knowlton, Paul E. Makidon, Luz Blanco, Jeffery V. Groom, II, Anna U. Bielinska
  • Nanoemulsion influenza vaccine
    Patent number: 9144606
    Abstract: The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: September 29, 2015
    Assignee: NanoBio Corporation
    Inventors: James R. Baker, Jr., Tarek Hamouda, Joyce A. Sutcliffe
  • Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
    Patent number: 9131680
    Abstract: Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfactants. Methods of making nanoemulsions and inactivating pathogenic microorganisms are also provided.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: September 15, 2015
    Assignee: NanoBio Corporation
    Inventors: Theodore C. Annis, James R. Baker, Tarek Hamouda
  • NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20150216826
    Abstract: The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a Burkholderia antigen) that generate an effective immune response (e.g., against a bacterial species of the genus Burkholderia) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.
    Type: Application
    Filed: February 23, 2015
    Publication date: August 6, 2015
    Inventors: James R. Baker, JR., Mark R. Hemmila, Stewart C. Wang, Tarek Hamouda, John J. LiPuma, Jessica Ann Knowlton, Paul E. Makidon, Luz Blanco, Jeffery V. Groom, II, Anna U. Bielinska
  • COMPOSITIONS FOR INACTIVATING PATHOGENIC MICROORGANISMS, METHODS OF MAKING THE COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20150150244
    Abstract: Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfactants. Methods of making nanoemulsions and inactivating pathogenic microorganisms are also provided.
    Type: Application
    Filed: April 1, 2014
    Publication date: June 4, 2015
    Applicant: NanoBio Corporation
    Inventors: Ted C. Annis, James R. Baker, Tarek Hamouda